By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A Boston-based hedge fund that holds a nearly 10 percent stake in Vermillion is seeking to make changes to the firm's bylaws in order to give shareholders a louder voice in the company and hold management more accountable, according to a letter it has sent to Vermillion executives.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.